Depression and Anxiety Trial, Recruiting NCT05691439 Sponsor: University of Oregon Condition: Depression and Anxiety
Back to Depression And Anxiety

Depression and Anxiety Trial, Recruiting

NCT05691439
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 14 and 18 years old
  • You are currently enrolled in high school
  • On school nights (weekdays), you either go to bed late (at or after 10:30 pm) and sleep 7 hours or less, OR you go to bed early (before 10:30 pm) and sleep more than 7 hours — this will be checked using a sleep questionnaire
  • You have experienced at least 2 stressful or difficult life events, based on a screening questionnaire
  • You have at least a mild level of depressive symptoms, based on a mood questionnaire
  • You can read and speak English fluently

Who may not be able to join:

  • You currently have a moderate or severe alcohol or drug use problem (showing 4 or more related symptoms)
  • You have been diagnosed by a doctor with narcolepsy or a condition causing excessive daytime sleepiness (idiopathic hypersomnia)
  • You have ever been diagnosed with bipolar disorder or a schizophrenia-related condition
  • You have certain serious medical conditions, such as a significant neurological disorder, serious heart problems, or a head injury that caused you to be unconscious for more than 5 minutes
  • You have metal or other materials in your body that would make an MRI scan unsafe (confirm with trial site)
  • You have an eye disease, epilepsy, or take certain medications that could be affected by bright light therapy — such as some psychiatric, heart, antimalarial, or skin treatment medications (confirm with trial site)
  • You currently take melatonin supplements and are not willing to stop taking them for the entire duration of the study

Additional scheduling notes (appointments may be rescheduled rather than disqualifying you):

  • You are currently considered at serious risk of suicide, as assessed by a clinician
  • You have traveled across two or more time zones within the month before an overnight study visit
  • You have recently started or stopped a prescribed medication within the past 2 months
  • Your prescribed medication dose has recently changed (confirm timing with trial site)
  • A change in your medications is expected during the study period
  • You have symptoms of a contagious airborne illness (such as a cold or flu) before a lab visit
  • You have a blood alcohol level above a very low threshold on the day of a visit (you would be rescheduled to another date)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 2 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Oregon
Registry
ClinicalTrials.gov
Start date
27 March 2023
Est. completion
31 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Patient-Reported Outcomes Measurement Information System (PROMIS) Pediatric Depression Scale - Short Form (8-item); Patient-Reported Outcomes Measurement Information System (PROMIS) Pediatric Positive Affect Scale - Short Form (8-item); Dimensional Anhedonia Rating Scale (DARS); Reward-related brain function; Stress-related brain function

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov